Latest Updates

Interview

Developing Smarter Insulin to Treat Diabetes with Robert Geho

February 28, 2019

Share this article
Interview

Latest Updates

News

Press Release

Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes

View Article
Press Release

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View Article
Study

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

View Article
View All